Comparative in vitro activities of new quinolones against coryneform bacteria.
AUTOR(ES)
Martínez-Martínez, L
RESUMO
The in vitro activities of eight quinolones against 115 coryneform bacteria (20 Corynebacterium jeikeium, 15 Corynebacterium minutissimum, 15 Corynebacterium striatum, 25 Corynebacterium urealyticum, 10 Corynebacterium xerosis, 10 Corynebacterium group ANF-1, 10 Corynebacterium group 12, and 10 Listeria monocytogenes) were determined. The MICs of ciprofloxacin, ofloxacin, and sparfloxacin for 90% of C. jeikeium, C. urealyticum, and C. xerosis isolates tested were > 16 micrograms/ml. Those of BAY Y 3118 and clinafloxacin against these species were 0.5 and 1 to 2 micrograms/ml, respectively. The MICs for 90% of all 115 strains tested were 0.5 microgram/ml for BAY Y 3118, 1 microgram/ml for clinafloxacin, 2 micrograms/ml for E-5068, 4 micrograms/ml for E-5065, and > 16 micrograms/ml for ciprofloxacin, ofloxacin, sparfloxacin, and E-4868.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=188228Documentos Relacionados
- In vitro activities of three of the newer quinolones against anaerobic bacteria.
- Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.
- Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.
- Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
- Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
